These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38603508)

  • 1. Modern approaches to therapeutic oligonucleotide manufacturing.
    Obexer R; Nassir M; Moody ER; Baran PS; Lovelock SL
    Science; 2024 Apr; 384(6692):eadl4015. PubMed ID: 38603508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid-Phase Oligonucleotide Synthesis: Past, Present, and Future Predictions.
    Molina AG; Sanghvi YS
    Curr Protoc Nucleic Acid Chem; 2019 Jun; 77(1):e82. PubMed ID: 30920171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent developments in the chemistry, analysis and control for the manufacture of therapeutic-grade synthetic oligonucleotides.
    Sinha ND; Michaud DP
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):807-18. PubMed ID: 17987530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An enzyme cascade enables production of therapeutic oligonucleotides in a single operation.
    Moody ER; Obexer R; Nickl F; Spiess R; Lovelock SL
    Science; 2023 Jun; 380(6650):1150-1154. PubMed ID: 37319201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustainability Challenges and Opportunities in Oligonucleotide Manufacturing.
    Andrews BI; Antia FD; Brueggemeier SB; Diorazio LJ; Koenig SG; Kopach ME; Lee H; Olbrich M; Watson AL
    J Org Chem; 2021 Jan; 86(1):49-61. PubMed ID: 33253568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From CPG to hybrid support: Review on the approaches in nucleic acids synthesis in various media.
    Brzezinska J; Trzciński S; Strzelec J; Chmielewski MK
    Bioorg Chem; 2023 Nov; 140():106806. PubMed ID: 37660625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical Synthesis and Biological Application of Modified Oligonucleotides.
    Glazier DA; Liao J; Roberts BL; Li X; Yang K; Stevens CM; Tang W
    Bioconjug Chem; 2020 May; 31(5):1213-1233. PubMed ID: 32227878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A status update of modified oligonucleotides for chemotherapeutics applications.
    Sanghvi YS
    Curr Protoc Nucleic Acid Chem; 2011 Sep; Chapter 4():Unit 4.1.1-22. PubMed ID: 21901670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in oligonucleotide synthesis and their applications.
    Vaijayanthi B; Kumar P; Ghosh PK; Gupta KC
    Indian J Biochem Biophys; 2003 Dec; 40(6):377-91. PubMed ID: 22900365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligonucleotide technologies: synthesis, production, regulations and applications. 29-30th November 2000, Hamburg, Germany.
    Uhlmann E
    Expert Opin Biol Ther; 2001 Mar; 1(2):319-28. PubMed ID: 11727539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic RNA-silencing oligonucleotides in metabolic diseases.
    Goga A; Stoffel M
    Nat Rev Drug Discov; 2022 Jun; 21(6):417-439. PubMed ID: 35210608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress toward oligonucleotide therapeutics: pharmacodynamic properties.
    Crooke ST
    FASEB J; 1993 Apr; 7(6):533-9. PubMed ID: 7682523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocatalytic Synthesis of Antiviral Nucleosides, Cyclic Dinucleotides, and Oligonucleotide Therapies.
    Van Giesen KJD; Thompson MJ; Meng Q; Lovelock SL
    JACS Au; 2023 Jan; 3(1):13-24. PubMed ID: 36711092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic oligonucleotides: the state-of-the-art in purification technologies.
    Sanghvi YS; Schulte M
    Curr Opin Drug Discov Devel; 2004 Nov; 7(6):765-76. PubMed ID: 15595437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Medicinal Chemistry of Therapeutic Oligonucleotides.
    Wan WB; Seth PP
    J Med Chem; 2016 Nov; 59(21):9645-9667. PubMed ID: 27434100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for Identity Testing of Therapeutic Oligonucleotide Drug Substances and Drug Products.
    Capaldi D; Akhtar N; Atherton T; Benstead D; Charaf A; De Vijlder T; Heatherington C; Hoernschemeyer J; Jiang H; Rieder U; Ring F; Peter R; Stolee JA; Wechselberger R
    Nucleic Acid Ther; 2020 Oct; 30(5):249-264. PubMed ID: 32857010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical Triphosphorylation of Oligonucleotides.
    Bare GAL; Horning DP
    J Vis Exp; 2022 Jun; (184):. PubMed ID: 35723475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An oligonucleotide synthesizer based on a microreactor chip and an inkjet printer.
    Li H; Huang Y; Wei Z; Wang W; Yang Z; Liang Z; Li Z
    Sci Rep; 2019 Mar; 9(1):5058. PubMed ID: 30911034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical strategies for the synthesis of peptide-oligonucleotide conjugates.
    Lu K; Duan QP; Ma L; Zhao DX
    Bioconjug Chem; 2010 Feb; 21(2):187-202. PubMed ID: 19856957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Oligonucleotides: An Outlook on Chemical Strategies to Improve Endosomal Trafficking.
    Mangla P; Vicentini Q; Biscans A
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.